Nanomedicine approaches for in vivo cancer immunotherapy.

Stijn Rj HofstraatTom Anbergen Roy van der Meel

Published in: Nanomedicine (London, England) (2023)

Tweetable abstract Commentary just out in @fsgnnm: unleashing the full potential of #cancer #nanomedicines by reprogramming the immunosuppressive #TME using #LNP #mRNA #vaccines and via promoting #trainedimmunity.

Keyphrases

papillary thyroid
squamous cell
cancer therapy
binding protein
human health
squamous cell carcinoma
risk assessment
young adults